Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

DexCom Q3 Adj. EPS $0.61 Beats $0.57 Estimate, Sales $1.209B Beat $1.179B Estimate

Author: Benzinga Newsdesk | October 30, 2025 03:03pm
DexCom (NASDAQ:DXCM) reported quarterly earnings of $0.61 per share which beat the analyst consensus estimate of $0.57 by 7.39 percent. This is a 35.56 percent increase over earnings of $0.45 per share from the same period last year. The company reported quarterly sales of $1.209 billion which beat the analyst consensus estimate of $1.179 billion by 2.56 percent. This is a 21.61 percent increase over sales of $994.200 million the same period last year.

Posted In: DXCM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist